Atlas Trials

Rimeporide in Patients With Duchenne Muscular Dystrophy

Clinical trial NCT02710591 · COMPLETED

Trial details

NCT number
NCT02710591
Sponsor
EspeRare Foundation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Muscular Dystrophy, Duchenne
Start date
2016-03-01
Primary completion
2017-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.